Bedford, Massachusetts
United States
14
2021-12-30
14
2022-03-29
These are the the leading inventors for applications assigned to Ixcela Inc.:
Ixcela Inc. based in Bedford, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
Detection and modification of gut microbial population
#2 | 2021-12-02 ✅ Patent 11,287,420 granted on 2022-03-29Detection and modification of gut microbial population
#3 | 2021-09-30 ✅ Patent 11,287,419 granted on 2022-03-29Detection and modification of gut microbial population
#4 | 2021-09-30 ✅ Patent 11,287,418 granted on 2022-03-29Detection and modification of gut microbial population
#5 | 2021-06-22 ✅ Patent 11,041,847 granted on 2021-06-22Detection and modification of gut microbial population
#6 | 2018-10-18 ✅ Patent 10,220,066 granted on 2019-03-05Treatment of virus-based diseases of the skin
#7 | 2018-10-18 ✅ Patent 10,213,468 granted on 2019-02-26Treatment of virus-based diseases of the skin
#8 | 2018-04-12 ✅ Patent 11,122,997 granted on 2021-09-21Modulating the aryl hydrocarbon receptor system to treat major depressive disorder
#9 | 2018-02-15 ✅ Patent 10,278,958 granted on 2019-05-07IPA as a protective agent
#10 | 2016-11-03 ✅ Patent 10,024,842 granted on 2018-07-17Methods and devices for quantitating blood samples
#11 | 2015-12-17 ✅ Patent 10,034,908 granted on 2018-07-31Treatment of virus-based diseases of the skin
#12 | 2015-08-06 ✅ Patent 9,636,325 granted on 2017-05-02Indole lactic acid or a mixture of indole lactic acid and indole-3-propionic acid for treatment of Huntington's disease
#13 | 2014-05-01 ✅ Patent 9,603,837 granted on 2017-03-28IPA as a therapeutic agent and a biomarker for disease risk for Huntington's disease
#14 | 2013-10-10 ✅ Patent 9,744,155 granted on 2017-08-29IPA as a therapeutic agent, as a protective agent, and as a biomarker of disease risk
Also check out IXCELA, INC.'s (Bedford, United States) applicant profile with 10 patent applications submitted.
133823 ⎘